Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid. | Biomolecules | 2026 | 41750253 | PubTator, text mining | PubMed |
| Oxygen-dependent modulation of the human complement system during acute normobaric hypoxia: a translational plasma proteomics study. | Clin Exp Med | 2026 | 41721929 | PubTator, text mining | PubMed |
| Complement C3 recognition by C3 convertases. | Sci Adv | 2026 | 41719406 | PubTator, text mining | PubMed |
| The insider's perspective: The intracellular complosome and immune cell dynamics in cancer. | Clin Transl Med | 2026 | 41719156 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma. | Med Sci (Basel) | 2026 | 41718124 | PubTator, text mining | PubMed |
| Impact of cellular proteases on the function of antiviral antibodies. | J Virol | 2026 | 41711444 | PubTator, text mining | PubMed |
| What is refractory CIDP? | BMJ Neurol Open | 2026 | 41710927 | PubTator, text mining | PubMed |
| Proteomic Signature in Men with Central Serous Chorioretinopathy. | J Proteome Res | 2026 | 41641862 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic regulation of Ca2+-signaling genes in hepatitis B-derived hepatocellular carcinoma and their association with the cancer hallmarks. | Bioinform Adv | 2026 | 41640621 | PubTator, text mining | PubMed |
| Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities. | Mamm Genome | 2026 | 41632207 | PubTator, text mining | PubMed |
| Prise en charge de l’urticaire chronique spontanée. | CMAJ | 2026 | 41628941 | PubTator, text mining | PubMed |
| Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID. | Immunology | 2026 | 41581925 | PubTator, text mining | PubMed |
| Pain management in patients with hereditary angioedema: A case report. | Medicine (Baltimore) | 2026 | 41578566 | PubTator, text mining | PubMed |
| Efficacy and acceptability of lanadelumab for long-term prophylaxis in hereditary angioedema: A Chinese multicenter real-world analysis. | World Allergy Organ J | 2026 | 41550678 | PubTator, text mining | PubMed |
| Chronic portal hypertension following inotuzumab ozogamicin in a low-risk patient: a case of overriding baseline risk and long-term management. | Ann Hematol | 2026 | 41528557 | PubTator, text mining | PubMed |
| Gut proteome and microbiome alterations: Analysis of transverse colon samples from pathologically confirmed Alzheimer's disease patients. | Alzheimers Dement | 2026 | 41527485 | PubTator, text mining | PubMed |
| Longitudinal proteomic and autoantibody signatures after mRNA vaccination in healthy individuals. | Vaccine | 2026 | 41313893 | PubTator, text mining | PubMed |
Corrigendum to "Substitution of reactive centre loop residues from C1 esterase inhibitor increases the inhibitory specificity of alpha-1 antitrypsin for plasma kallikrein" [J. Biotechnol. 405 (2025) 205-214]. | J Biotechnol | 2026 | 41207264 | PubTator, text mining | PubMed |
| Synaptic pruning genes networks in Alzheimer's disease: correlations with neuropathology and cognitive decline. | Geroscience | 2026 | 40515808 | PubTator, text mining | PubMed |
| Differential expression of complement Properdin and Factor H in the placentae and umbilical cords of mothers with Preeclampsia, Gestational Diabetes Mellitus and Recurrent Pregnancy Loss. | Front Immunol | 2025 | 41710025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=3